Latest Pathology News
U.S. Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research
posted May 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
The U.S. Department of Health and Human Services said Thursday it would provide up to $1.2 billion to AstraZeneca to develop a potential COVID-19 vaccine from a lab in Oxford, England.
Clinical Genetic Testing for Autism Remains Very Low
posted May 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
SARS-CoV-2 Antibodies Detected in 4.65 Percent in Los Angeles County
posted May 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
U.S. Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research
posted May 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Elevated C-Reactive Protein Linked to Increased Risk for Incident Heart Failure, All-Cause Mortality .jpg)
U.S. Study Shows Blood-Based Multicancer Early Detection Test Can ID Cancer Signals 
Steatotic Liver Disease Risk Scores Compared for Predicting Cirrhosis Pathology Conference Highlights
Pathology Monthly Briefings
Pathology Conference News
Stay Connected
